0G8X.LImmunovia AB

À propos

Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

www.immunovia.com

Statistiques clés

Capitalisation

66.38M

BPA

-0.42

Rendement dividende

0.00%

Bêta

2.68

P/B

1.21

ROE

-225.4%

Secteur

Healthcare

Industrie

Medical - Pharmaceuticals

PDG

Jeff Borcherding

Employés

13

Date IPO

2018-01-26

Pays

SE